IEEE Pulse. 2026 Mar-Apr;17(2):23-26. doi: 10.1109/MPULS.2026.3677910.
ABSTRACT
A new generation of noninvasive, FDA-cleared devices is making continuous heart monitoring more accessible to address cardiovascular disease. As healthcare shifts toward outcomes-based models, these technologies promise more proactive, equitable monitoring and care, though challenges around ease of usability and clinician trust persist.
PMID:42284185 | DOI:10.1109/MPULS.2026.3677910